Amanta Healthcare Limited submitted its financial results for the quarter and year ended March 31, 2026 to the NSE on May 19, 2026, following a board meeting held the same day. The announcement triggered a positive market response, with the stock closing at ₹132, a gain of ₹6.18 or 4.91% on the day of disclosure.
Result Announcement and Trading Activity
The board meeting outcome was filed with the exchange at 15:36 IST on May 19, 2026, confirming submission of audited financials for the period ended March 31, 2026. Trading volume on announcement day stood at 69,517 shares, with a delivery percentage of 57.05%. A delivery ratio above 50% is generally considered indicative of conviction-based buying rather than intraday speculation, suggesting that a meaningful portion of participants were taking positional exposure following the results disclosure.
Valuation and Market Metrics
At the current market price of ₹132, Amanta Healthcare carries a market capitalisation of ₹512.55 Cr, placing it in the small-cap segment. The company's price-to-earnings ratio is currently not available, and sector PE data is similarly unavailable, which limits direct peer comparison at this stage. Investors should note that the absence of a reported PE figure may reflect a net loss position or pending finalisation of consolidated earnings, details of which were not disclosed in the exchange filing.
52-Week Price Context
The stock's 52-week high stands at ₹154.40, recorded on September 23, 2025, while its 52-week low of ₹92 was touched on March 16, 2026. At the current price of ₹132, the stock is trading 14.5% below its 52-week high and 43.5% above its 52-week low. The sharp recovery from the March 2026 low of ₹92 to the current level of ₹132 represents a rebound of over 43% in approximately two months, coinciding with the approach of the full-year results announcement.
Dividend History
No dividend history is available on record for Amanta Healthcare Limited. The company has not declared any dividend alongside the March 2026 results announcement, and there is no prior dividend data to establish a yield or payout trend for income-focused investors.
Company Background
Amanta Healthcare Limited, trading under the NSE symbol AMANTA with ISIN INE084K01015, operates in the healthcare sector. The company is a small-cap listed entity with its registered financials now submitted for regulatory review following the FY26 annual close.
What Investors Should Note
- The actual financial figures including revenue, net profit or loss, and margins were not included in the exchange announcement text and have not been disclosed in this filing summary.
- Daily volatility is recorded at 1.83%, indicating moderate short-term price movement risk for the stock.
- The absence of PE data and dividend history means fundamental valuation relative to peers remains difficult to assess without the detailed results document.
- Investors are advised to review the full financial results document filed by the company on the NSE platform for complete income statement and balance sheet data.
The complete audited financial statements for FY26 are available on the NSE disclosures portal under the AMANTA scrip code for detailed review.